METHODS AND COMPOSITIONS FOR PREDICTING RESPONSE TO ERIBULIN
摘要
The invention provides methods for predicting the efficacy of eribulin, an analog thereof, or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate), in the treatment of a subject suffering from breast cancer by determining the level of particular biomarkers in a sample derived from the subject.
申请公布号
SG193489(A1)
申请公布日期
2013.10.30
申请号
SG20130069646
申请日期
2012.03.16
申请人
EISAI R&D MANAGEMENT CO., LTD.
发明人
AGOULNIK, SERGEI, I.;BYRNE, MICHAEL, CHAPMAN;LITTLEFIELD, BRUCE, A.